首页>
外国专利>
Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3
Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3
展开▼
机译:基于谷胱甘肽毒素3表达水平的肺癌和大肠癌的诊断或预后
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a biomarker for diagnosing lung cancer and colorectal cancer containing glutaredoxin 3 as an active ingredient, and a kit for diagnosing lung cancer and colorectal cancer using the same biomarker. Glutaredoxin 3 of the present invention is over-expressed in lung cancer tissue and colorectal cancer tissue, which enables early prediction of diagnosis or prognosis of lung cancer and colorectal cancer. Thus, glutaredoxin 3 can be helpfully used as a biomarker for diagnosing lung cancer and colorectal cancer.
展开▼